2 Under-the-Radar Pharma M&A Targets for 2018 Post author:Sam Post published:January 10, 2018 Post category:BioPharma A look at why these two biopharma companies could have targets on their backs. Source: BioSpace You Might Also Like FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab July 30, 2017 <b>Gates</b>-Backed Cambridge Startup Affinivax Grabs $10 Million+ Deal With Japanese Drug Giant Astellas February 27, 2017 Radius Health To Announce Second Quarter 2017 Financial Results, Host Conference Call And Live Webcast On August 3, 2017 July 6, 2017
<b>Gates</b>-Backed Cambridge Startup Affinivax Grabs $10 Million+ Deal With Japanese Drug Giant Astellas February 27, 2017
Radius Health To Announce Second Quarter 2017 Financial Results, Host Conference Call And Live Webcast On August 3, 2017 July 6, 2017
